Contraception
📧 Sign up to get email alerts when something new happens for Contraception.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-04-29FDA Approved: LEVORA — Supplemental Application (Mayne Pharma Inc.)
The FDA approved a supplemental application for LEVORA (levonorgestrel and ethinyl estradiol) from Mayne Pharma, updating the product labeli…
-
FDA approval · 2022-04-29FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Naari Pte Limited)
FDA approved a supplemental application for a combined oral contraceptive tablet containing norethindrone, ethinyl estradiol, and ferrous fu…
-
FDA approval · 2022-04-29FDA Approved: CRYSELLE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for CRYSELLE (norgestrel and ethinyl estradiol) from Teva Pharmaceuticals, updating the labeling via…
-
FDA approval · 2022-04-29FDA Approved: HAILEY 24 FE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for HAILEY 24 FE, a generic combined oral contraceptive containing norethindrone acetate and ethinyl…
-
FDA approval · 2022-04-29FDA Approved: NORELGESTROMIN AND ETHINLY ESTRADIOL — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for the generic combined oral contraceptive product NORELGESTROMIN AND ETHINLY ESTRADIOL from Am…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-04-29FDA Approved: VYLIBRA — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for VYLIBRA (norgestimate and ethinyl estradiol) from Afaxys Pharma, LLC.
-
FDA approval · 2022-04-29FDA Approved: CYRED EQ — Supplemental Application (Afaxys Pharma, LLC)
The FDA approved a supplemental application for CYRED EQ (desogestrel and ethinyl estradiol) from Afaxys Pharma, LLC. The product is a combi…
-
FDA approval · 2022-04-29FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Levonorgestrel and Ethinyl Estradiol product from Mylan Pharmaceuticals under the …
-
FDA approval · 2022-04-29FDA Approved: ALTAVERA — Supplemental Application (Xiromed, LLC.)
FDA approved a supplemental application for ALTAVERA, a generic combined oral contraceptive containing levonorgestrel and ethinyl estradiol,…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Mirena Extension Trial [Phase 3]
Phase 3 Mirena extension trial for contraception has completed with results posted.
-
FDA approval · 2022-04-22FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for CHATEAL EQ, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submi…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: A Study of Oral Contraception Under Simulated OTC Conditions [Phase 3]
Phase 3 trial of an oral contraceptive under simulated OTC conditions was terminated.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception [Phase 3]
Phase 3 trial comparing CDB-2914 to levonorgestrel for emergency contraception completed with posted results.
-
FDA approval · 2022-03-04FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for LEVONORGESTREL AND ETHINYL ESTRADIOL submitted by Mylan Pharmaceuticals Inc., resulting in an ap…
-
FDA approval · 2022-03-03FDA Approved: MICROGESTIN 24 FE — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for MICROGESTIN 24 FE (norethindrone acetate/ethinyl estradiol and ferrous fumarate) from Mayne Phar…
-
FDA approval · 2022-02-28FDA Approved: LOW-OGESTREL — Supplemental Application (Mayne Pharma Inc.)
The FDA approved a supplemental application for Low-Ogestrel, a combined oral contraceptive containing norgestrel and ethinyl estradiol, fro…
-
CLINICAL_TRIALS research · 2022-02-23Clinical Trial Update: Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research. [Phase 4]
Phase 4 clinical trial update inviting participants for uterovaginal plexus block with articaine during copper IUD placement.
-
FDA approval · 2022-02-22FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for norethindrone acetate and ethinyl estradiol submitted by Nivagen Pharmaceuticals, Inc. The a…
-
FDA approval · 2022-02-16FDA Approved: JUNEL FE 24 — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for JUNEL FE 24, a combined oral contraceptive containing norethindrone acetate and ethinyl estr…
-
CLINICAL_TRIALS withdrawal · 2022-02-16Clinical Trial Update: Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017) [Phase 3]
Phase 3 trial of oral NOMAC-E2 for contraception in Indian women has been withdrawn.
-
FDA approval · 2022-02-10FDA Approved: NORTREL 21 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for Nortrel 21 Day, a generic combination oral contraceptive containing norethindrone and e…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED) [Phase 4]
Phase 4 trial update evaluating contraceptive efficacy and safety of the etonogestrel subdermal implant Implanon® (P06473) has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) [Phase 2]
Phase 2 trial update on hormonal contraception in healthy young men has completed.
-
FDA approval · 2022-02-03FDA Approved: MONO-LINYAH — Supplemental Application (Northstar Rx LLC)
FDA approved a supplemental application for MONO-LINYAH, a combined oral contraceptive containing norg estimate and ethinyl estradiol, submi…
-
FDA approval · 2022-02-03FDA Approved: NORGESTIMATE AND ETHINYL ESTRADIOL — Supplemental Application (AvKARE)
The FDA approved AvKARE's supplemental application for a generic combined oral contraceptive containing norgestimate and ethinyl estradiol.